MSOS

Dopo l'orario di chiusura: 7.15 -0.02 -0.28%

Advisorshares Pure Us Cannabis Etf (MSOS)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Advisorshares Pure Us Cannabis Etf Stock (MSOS) Company Profile

Advisorshares Pure Us Cannabis Etf

Prossima data di guadagno

Ultimi documenti SEC

MSOS's Discussions on Twitter

Advisorshares Pure Us Cannabis Etf Borsa (MSOS) Ultime notizie

Advisorshares Pure Us Cannabis Etf Azioni (MSOS) Dati Finanziari

Non sono disponibili dati finanziari per Advisorshares Pure Us Cannabis Etf (MSOS). Controlla altri titoli per ulteriori informazioni.

Advisorshares Pure Us Cannabis Etf (MSOS)

Advisorshares Pure Us Cannabis Etf Stock (MSOS) Company Profile

Advisorshares Pure Us Cannabis Etf Borsa (MSOS) Ultime notizie

Cabot Cannabis Investor Issue: September 25, 2024 - Cabot Wealth Network

(MSOS) Investment Analysis - Stock Traders Daily

Cannabis Investor Sentiment Softens As Institutional Confidence Wanes, Survey Shows - Benzinga

What investors need to know about active bond ETFs as Fed prepares rate cuts - MarketWatch

The Economic Benefits of Legalizing Marijuana - Investopedia

Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate - Benzinga

5 ETFs That Led the Rebound on Monday - Yahoo Finance

Cannabis stocks rally as Trump backs rescheduling, Florida legalization - Proactive Investors USA

Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence. - The Motley Fool

Cannabis Legalization Is Very Popular. Here’s Why the Stocks Aren’t. - Barron's

(MSOS) Trading Signals - Stock Traders Daily

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit? - Benzinga

Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan’ issue - MarketWatch

6 Best-Performing Marijuana ETFs for September 2024 - NerdWallet

This small-cap ETF drew investors after Fed nod to rate cuts. Can it keep it up? - MarketWatch

Cannabis Stocks Tumble on News of DEA’s Rescheduling Shakeup - mg Magazine

Cheaper Than A Big Mac: Weed Penny Stocks Emerge As Winners Amidst Market Downturn - Benzinga

Small caps and the U.S. election: How investors can win in the home stretch - Kursiv Media

AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Down to $7.04 - Defense World

Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - MSN

Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - Invezz

Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - Reuters

Cabot Cannabis Investor Issue: August 28, 2024 - Cabot Wealth Network

Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris - Benzinga

Rescheduling Delay Sends Cannabis Stocks Into Tailspin - Business of Cannabis -

Stock Traders Buy High Volume of Call Options on AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) - Defense World

Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - ETHealthWorld

Cannabis stocks slide after DEA decides to push back reclassification hearing - Mugglehead

Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - WKZO

Cannabis stocks tumble as rescheduling hopes get slapped - Crain's Cleveland Business

Cannabis stocks tumble as rescheduling hopes get slapped - Green Market Report

Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - Yahoo Canada Finance

Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - WHBL

Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024? - AOL

Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election - Proactive Investors Australia

Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024? - Benzinga

Cannabis stocks on watch as DEA sets hearing on marijuana rescheduling - Seeking Alpha

New SEC Filings Reveal Risks In Cannabis ETFs Following Recent Volatility — But There's Still Room For Optimism (CORRECTED)4Front Ventures (OTC:FFNTF), Green Thumb Industries (OTC:GTBIF) - Benzinga

AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Up to $7.58 - Defense World

1 Cannabis ETF for Penny Stock Traders to Consider - Nasdaq

Advisorshares Pure Us Cannabis Etf Azioni (MSOS) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a MSOS